These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33515532)

  • 21. Arrangement of Proteinogenic α-Amino Acids on a Cyclic Peptide Comprising Alternate Biphenyl-Cored ζ-Amino Acids.
    Tashiro S; Chiba M; Shionoya M
    Chem Asian J; 2017 May; 12(10):1087-1094. PubMed ID: 28387471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Advances in Synthesis and Identification of Cyclic Peptides for Bioapplications.
    Ong YS; Gao L; Kalesh KA; Yu Z; Wang J; Liu C; Li Y; Sun H; Lee SS
    Curr Top Med Chem; 2017; 17(20):2302-2318. PubMed ID: 28240181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marine Peptides as Anticancer Agents: A Remedy to Mankind by Nature.
    Negi B; Kumar D; Rawat DS
    Curr Protein Pept Sci; 2017; 18(9):885-904. PubMed ID: 27455970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting cancer-specific glycans by cyclic peptide lectinomimics.
    Rodriguez MC; Yongye AB; Cudic M; Martinez Mayorga K; Liu E; Mueller BM; Ainsley J; Karabencheva-Christova T; Christov CZ; Cudic M; Cudic P
    Amino Acids; 2017 Nov; 49(11):1867-1883. PubMed ID: 28894966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of anti-cancer cyclopeptides containing triazole skeleton.
    Tahoori F; Balalaie S; Sheikhnejad R; Sadjadi M; Boloori P
    Amino Acids; 2014 Apr; 46(4):1033-46. PubMed ID: 24420338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyclic Peptides: Types, Synthesis and Applications.
    Khazaei-Poul Y; Farhadi S; Ghani S; Ahmadizad SA; Ranjbari J
    Curr Pharm Biotechnol; 2021; 22(1):123-135. PubMed ID: 31987019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico predictions of 3D structures of linear and cyclic peptides with natural and non-proteinogenic residues.
    Beaufays J; Lins L; Thomas A; Brasseur R
    J Pept Sci; 2012 Jan; 18(1):17-24. PubMed ID: 22033979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases.
    Szokolóczi O; Schwab R; Peták I; Orfi L; Pap A; Eberle AN; Szüts T; Kéril G
    J Recept Signal Transduct Res; 2005; 25(4-6):217-35. PubMed ID: 16393913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress in the study of some important natural bioactive cyclopeptides].
    Xu WY; Zhao SM; Zeng GZ; He WJ; Xu HM; Tan NH
    Yao Xue Xue Bao; 2012 Mar; 47(3):271-9. PubMed ID: 22645749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of Tumor Growth and Metastases by Targeted Intervention in Urokinase Activity with Cyclic Peptides.
    Wang D; Yang Y; Jiang L; Wang Y; Li J; Andreasen PA; Chen Z; Huang M; Xu P
    J Med Chem; 2019 Feb; 62(4):2172-2183. PubMed ID: 30707839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy.
    Guisado-Vasco P; González-Cortijo L; D'Errico G; Serrera-Alvarez A; Sotres-Fernandez G; García-Coca M; Fernández-Sousa JM; Luepke-Estefan XE; López-Martín JA; Jimeno JM
    Ann Oncol; 2021 Oct; 32(10):1295-1297. PubMed ID: 34242743
    [No Abstract]   [Full Text] [Related]  

  • 32. Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.
    Msaouel P; Galanis E; Koutsilieris M
    Expert Opin Investig Drugs; 2009 Sep; 18(9):1297-316. PubMed ID: 19678799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The endothelin axis: a novel target for pharmacotherapy of female malignancies.
    Smollich M; Wülfing P
    Curr Vasc Pharmacol; 2007 Jul; 5(3):239-48. PubMed ID: 17627567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aplidin PharmaMar.
    Yao L
    IDrugs; 2003 Mar; 6(3):246-50. PubMed ID: 12789614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FR-901228 Fujisawa/National Cancer Institute.
    Vigushin DM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1396-402. PubMed ID: 12498018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides.
    Trinh TB; Upadhyaya P; Qian Z; Pei D
    ACS Comb Sci; 2016 Jan; 18(1):75-85. PubMed ID: 26645887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.
    Wang T; Wu X; Guo C; Zhang K; Xu J; Li Z; Jiang S
    J Med Chem; 2019 Feb; 62(4):1715-1730. PubMed ID: 30247903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic Peptides Made by Linking Synthetic and Genetically Encoded Fragments.
    Palei S; Mootz HD
    Chembiochem; 2016 Mar; 17(5):378-82. PubMed ID: 26691013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice.
    Vilchis-Juárez A; Ferro-Flores G; Santos-Cuevas C; Morales-Avila E; Ocampo-García B; Díaz-Nieto L; Luna-Gutiérrez M; Jiménez-Mancilla N; Pedraza-López M; Gómez-Oliván L
    J Biomed Nanotechnol; 2014 Mar; 10(3):393-404. PubMed ID: 24730235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seek & Destroy, use of targeting peptides for cancer detection and drug delivery.
    Le Joncour V; Laakkonen P
    Bioorg Med Chem; 2018 Jun; 26(10):2797-2806. PubMed ID: 28893601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.